Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TransMedics Group, Inc.
Report date February 01, 2023 · Filed February 03, 2023
Section 16 reporting ended · disclosed 2023-02-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,120 |
Ending reported balance
After 2023-02-01 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2023-02-01 · Exercise / conversion · Acquired 1,363 · Balance 15,483 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Row 2 · 2023-02-01 · Exercise / conversion · Acquired 47 · Balance 15,530 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Row 3 · 2023-02-01 · Sale · Disposed 582 · Balance 14,948 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 4 · 2023-02-01 · Sale · Disposed 379 · Balance 14,569 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 5 · 2023-02-01 · Sale · Disposed 96 · Balance 14,473 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 6 · 2023-02-01 · Sale · Disposed 139 · Balance 14,334 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 7 · 2023-02-01 · Sale · Disposed 214 · Balance 14,120 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.14 · Expires 2030-02-27 | Direct | 4,887 |
Reported balance
After 2023-02-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-02-01 · Exercise / conversion · Disposed 1,363 · Balance 4,887 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F7: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.46 · Expires 2031-02-24 | Direct | 13,543 |
Reported balance
After 2023-02-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-02-01 · Exercise / conversion · Disposed 47 · Balance 13,543 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F8: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F7: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
F8: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2022 Filed Aug 2, 2022 00:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,041 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000899243-22-027258 · doc4.xml · derivative · entry 8 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,834 Underlying: Common Stock · 2,041 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F7 · derivative.exercise_date: The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 22, 2022. As of the date of this report, the option remains subject to vesting with respect to 34,042 shares. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 00:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 4,000 | $40.01 | $160,040.00 |
DisclosureSEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.00 to $40.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 00:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,959 | $2.21 | $4,329.39 |
DisclosureSEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 00:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,041 | $13.28 | $27,104.48 |
DisclosureSEC source: 0000899243-22-027258 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · balance_after: The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,125 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000899243-22-026586 · doc4.xml · derivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,875 Underlying: Common Stock · 1,125 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 22, 2022. As of the date of this report, the option remains subject to vesting with respect to 34,042 shares. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 375 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-22-026586 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 375 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. As of the date of this report, the option remains subject to vesting with respect to 6,250 shares. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,500 | $34.57 | $51,855.00 |
DisclosureSEC source: 0000899243-22-026586 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $34.50 to $34.71, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,125 | $13.28 | $14,940.00 |
DisclosureSEC source: 0000899243-22-026586 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 375 | $16.14 | $6,052.50 |
DisclosureSEC source: 0000899243-22-026586 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2022 Filed Jul 12, 2022 21:27 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-22-025989 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,625 Underlying: Common Stock · 1,500 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. As of the date of this report, the option remains subject to vesting with respect to 6,250 shares. Read SEC document |
| July 11, 2022 Filed Jul 12, 2022 21:27 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,500 | $32.98 | $49,470.00 |
DisclosureSEC source: 0000899243-22-025989 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.60 to $33.49, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 11, 2022 Filed Jul 12, 2022 21:27 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,500 | $16.14 | $24,210.00 |
DisclosureSEC source: 0000899243-22-025989 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 28, 2022 Filed Jun 29, 2022 22:05 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,724 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-024533 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,489 Underlying: Common Stock · 2,724 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 28, 2022 Filed Jun 29, 2022 22:05 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,724 | $32.87 | $89,537.88 |
DisclosureSEC source: 0000899243-22-024533 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.50 to $33.03, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 28, 2022 Filed Jun 29, 2022 22:05 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,724 | $0.28 | $762.72 |
DisclosureSEC source: 0000899243-22-024533 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 27, 2022 Filed Jun 27, 2022 23:59 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,320 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-024252 · doc4.xml · derivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,213 Underlying: Common Stock · 3,320 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 27, 2022 Filed Jun 27, 2022 23:59 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 3,320 | $32.59 | $108,198.80 |
DisclosureSEC source: 0000899243-22-024252 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.52 to $32.76, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 27, 2022 Filed Jun 27, 2022 23:59 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,320 | $0.28 | $929.60 |
DisclosureSEC source: 0000899243-22-024252 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 23:59 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,956 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-024252 · doc4.xml · derivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,533 Underlying: Common Stock · 2,956 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 23:59 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,956 | $32.57 | $96,276.92 |
DisclosureSEC source: 0000899243-22-024252 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.50 to $32.72, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 23:59 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,956 | $0.28 | $827.68 |
DisclosureSEC source: 0000899243-22-024252 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-021002 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,489 Underlying: Common Stock · 1,500 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 522 | $28.74 | $15,002.28 |
DisclosureSEC source: 0000899243-22-021002 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $28.35 to $29.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 978 | $27.89 | $27,276.42 |
DisclosureSEC source: 0000899243-22-021002 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 901 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $27.35 to $28.33, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,500 | $0.28 | $420.00 |
DisclosureSEC source: 0000899243-22-021002 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 04, 2022 Filed May 6, 2022 20:05 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-017082 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,989 Underlying: Common Stock · 1,500 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 04, 2022 Filed May 6, 2022 20:05 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,500 | $25.31 | $37,965.00 |
DisclosureSEC source: 0000899243-22-017082 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $25.16 to $25.40, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 04, 2022 Filed May 6, 2022 20:05 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,500 | $0.28 | $420.00 |
DisclosureSEC source: 0000899243-22-017082 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 22:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-013454 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,489 Underlying: Common Stock · 1,500 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 22:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,500 | $26.85 | $40,275.00 |
DisclosureSEC source: 0000899243-22-013454 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $26.37 to $27.24, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 22:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,500 | $0.28 | $420.00 |
DisclosureSEC source: 0000899243-22-013454 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 23:19 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 157 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-012842 · doc4.xml · derivative · entry 7 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,989 Underlying: Common Stock · 157 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 23:19 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,530 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-012842 · doc4.xml · derivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,743 Underlying: Common Stock · 1,530 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 23:19 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,813 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-22-012842 · doc4.xml · derivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,125 Underlying: Common Stock · 2,813 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 23:19 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 4,500 | $25.01 | $112,545.00 |
DisclosureSEC source: 0000899243-22-012842 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $25.00 to $25.05, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: The amount of securities directly owned by the Reporting Person includes 379 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 23:19 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 157 | $0.28 | $43.96 |
DisclosureSEC source: 0000899243-22-012842 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · balance_after: The amount of securities directly owned by the Reporting Person includes 379 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 23:19 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,530 | $2.21 | $3,381.30 |
DisclosureSEC source: 0000899243-22-012842 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · balance_after: The amount of securities directly owned by the Reporting Person includes 379 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 23:19 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,813 | $16.14 | $45,401.82 |
DisclosureSEC source: 0000899243-22-012842 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · balance_after: The amount of securities directly owned by the Reporting Person includes 379 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:49 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 38,000 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000899243-22-007685 · doc4.xml · derivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-042421 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,273 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,680 | $28.16 | $47,308.80 |
DisclosureSEC source: 0000899243-21-042421 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $27.48 to $28.44, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:45 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,680 | $2.21 | $3,712.80 |
DisclosureSEC source: 0000899243-21-042421 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:52 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-039217 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,953 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:52 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 980 | $32.74 | $32,085.20 |
DisclosureSEC source: 0000899243-21-039217 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.37 to $33.12, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:52 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 700 | $31.76 | $22,232.00 |
DisclosureSEC source: 0000899243-21-039217 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 980 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $31.31 to $32.30, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:52 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,680 | $2.21 | $3,712.80 |
DisclosureSEC source: 0000899243-21-039217 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:14 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-035143 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,633 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:14 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 600 | $32.37 | $19,422.00 |
DisclosureSEC source: 0000899243-21-035143 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.29 to $32.60, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:14 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,080 | $31.77 | $34,311.60 |
DisclosureSEC source: 0000899243-21-035143 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $31.27 to $32.23, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:14 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,680 | $2.21 | $3,712.80 |
DisclosureSEC source: 0000899243-21-035143 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.